GO:1990960 basophil homeostasis: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990960 basophil homeostasis is the biological process that keeps the total number of basophils stable over time in the absence of an outside stimulus, balancing basophil proliferation and elimination.
• Basophils are rare circulating granulocytes whose differentiation and survival are instructed by cytokines such as IL-3, TSLP and IL-33.
• Basophil homeostasis is not a passive steady state; it is actively modulated during helminth infection and allergic inflammation.
• IL-33 and its receptor ST2 are central regulators of basophil effector function and of the tissue signals that feed back on basophil numbers.
• Dysregulated basophil homeostasis contributes to type 2 inflammation in atopic dermatitis, chronic rhinosinusitis and nasal polyposis.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate genes in basophil homeostasis.
Description
Basophils are the least abundant granulocytes in peripheral blood, yet they are potent sources of histamine, leukotrienes and type 2 cytokines. The Gene Ontology term GO:1990960, basophil homeostasis, captures the regulatory process that keeps the total number of basophils within a whole or part of an organism stable over time in the absence of an outside stimulus. In practical terms, this term describes the balance between basophil production, survival and removal that maintains a stable basophil pool. Understanding this process matters because basophil numbers and activation states are altered in allergic and helminth-driven immune responses, and because basophils can amplify type 2 inflammation in barrier tissues. Recent reviews emphasize that basophil differentiation, heterogeneity and functional implications are tightly linked to the cytokine environment, which directly influences homeostatic set points. Interleukin-33 (IL-33) is a nuclear cytokine of the IL-1 family that is released as an extracellular alarmin and acts on basophils and other type 2 immune cells, thereby shaping basophil effector function and the tissue context in which basophil homeostasis operates. Because basophils are rare, mechanistic studies of their homeostasis require sensitive genetic and functional tools, including CRISPR-based models that can test whether a candidate gene causally alters basophil numbers or function.
basophil homeostasis At A Glance
| GO ID | GO:1990960 |
|---|---|
| GO term | basophil homeostasis |
| Ontology | biological_process |
| Synonym | basophilic leucocyte homeostasis |
| Major function | Regulation of basophil proliferation and elimination to keep total basophil numbers stable over time in the absence of an outside stimulus |
| Cell type | Basophils, rare circulating granulocytes of the type 2 immune axis |
| Key cytokines | IL-3, TSLP, IL-33 and related type 2 cytokines instruct basophil differentiation and survival |
| Disease relevance | Type 2 inflammation in atopic dermatitis, chronic rhinosinusitis and nasal polyposis |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, flow cytometry and cytokine profiling |
What Is GO:1990960?
GO:1990960 basophil homeostasis is defined by QuickGO as the process of regulating the proliferation and elimination of basophils such that the total number of basophils within a whole or part of an organism is stable over time in the absence of an outside stimulus. The synonym basophilic leucocyte homeostasis is used interchangeably. In other words, this term covers the intrinsic and microenvironmental mechanisms that balance basophil generation, survival and clearance to maintain a stable basophil pool under resting conditions.
Why Is basophil homeostasis Important in Cell Biology?
Basophil homeostasis is important because basophils sit at the interface between innate sensing and type 2 adaptive immunity, and their numbers must be kept within a narrow range to avoid inappropriate inflammation. When homeostatic control is perturbed, basophils can accumulate or become hyper-responsive, contributing to type 2 inflammation in skin and airway disease. Conversely, during helminth infection, basophil effector function and homeostasis are actively remodeled to support host defense. Because cytokine instruction, including IL-33 and TSLP signaling, directly modulates basophil differentiation and survival, the homeostatic set point is a measurable and experimentally tractable phenotype. Researchers therefore study GO:1990960 to understand how the immune system maintains a stable basophil pool and how that pool is redeployed in infection and allergy.
• Defines the steady-state set point for a rare but potent type 2 immune cell population.
• Provides a framework for interpreting basophil counts in allergic and helminth-driven responses.
• Links cytokine instruction, especially IL-3 and TSLP, to basophil differentiation and survival.
• Connects IL-33/ST2 alarmin signaling to basophil effector function and tissue inflammation.
• Relevant to atopic dermatitis, where type 2 inflammation contributes to skin barrier dysfunction.
• Relevant to chronic rhinosinusitis and nasal polyposis, where type 2 immunity drives pathology.
• Supports development of CRISPR models to test causal genes in basophil homeostasis.
• Helps distinguish homeostatic basophil regulation from emergency or infection-driven basophilia.
• Guides flow cytometry and cytokine profiling strategies for rare granulocyte populations.
• Informs therapeutic hypotheses targeting type 2 cytokine networks in barrier tissues.
What Happens During basophil homeostasis?
Basophil differentiation from progenitors
In simple terms: Basophils are made from precursor cells in the bone marrow, and this production step sets the size of the basophil pool.
Basophil homeostasis begins with the differentiation of basophils from hematopoietic progenitors. Recent reviews describe basophil differentiation as a cytokine-instructed process in which the available cytokine milieu determines the yield and phenotype of maturing basophils. Cytokine instruction is a general principle of basophil modulation, meaning that signals present during development can change the number and functional state of the cells that are produced. This differentiation step is the first point at which the total basophil number can be regulated, and it is therefore a core component of GO:1990960.
Cytokine-dependent survival and proliferation
In simple terms: Once basophils exist, cytokines act like survival signals that keep them alive and allow them to multiply.
After differentiation, basophil numbers are maintained by cytokine-dependent survival and proliferation signals. Basophil modulation by cytokine instruction is well established, and cytokines such as IL-3 and TSLP are recognized as key instructors of basophil responses. IL-33, a nuclear cytokine of the IL-1 family, is released as an extracellular alarmin and can act on basophils and other type 2 immune cells, thereby influencing their effector function and the tissue environment that supports them. Because these signals can be produced locally in tissues, they provide a mechanism by which basophil homeostasis can be tuned without an outside stimulus.
Elimination and turnover of basophils
In simple terms: To keep the number stable, old or excess basophils must be removed at the same rate that new ones are made.
Homeostasis requires elimination as well as production. The QuickGO definition of GO:1990960 explicitly includes the regulation of basophil elimination such that total numbers remain stable over time in the absence of an outside stimulus. Studies of basophil effector function and homeostasis during helminth infection show that basophil numbers and activation states are dynamically regulated in vivo, indicating that turnover and removal are active processes rather than passive decay. This balance between production and elimination is what distinguishes homeostasis from simple accumulation.
Tissue signals and feedback on basophil numbers
In simple terms: Signals from tissues tell the body whether more or fewer basophils are needed, feeding back on the homeostatic set point.
Basophil homeostasis is influenced by tissue-derived signals that report the state of the local environment. IL-33 is released as a potent extracellular cytokine and acts as an alarmin in barrier tissues, where it can shape type 2 immune responses. In skin disorders, group 2 innate lymphoid cells and related type 2 circuits respond to such signals, and basophils participate in the same type 2 network. In atopic dermatitis, type 2 inflammation contributes to skin barrier dysfunction, illustrating how tissue signals and immune cell homeostasis are coupled. These feedback loops allow basophil numbers to remain stable under resting conditions while remaining responsive to tissue needs.
Integration with type 2 inflammation
In simple terms: Basophil homeostasis is part of the larger type 2 immune system, so changes in that system can shift basophil numbers.
Basophil homeostasis does not operate in isolation; it is embedded in the broader type 2 immune network. Chronic rhinosinusitis and nasal polyposis are characterized by type 2 inflammation in which multiple cell types, including basophils, contribute to pathology. In atopic dermatitis, type 2 inflammation drives skin barrier dysfunction, and basophils are part of the type 2 cellular landscape. ILC2s in skin disorders further illustrate how type 2 circuits are organized in barrier tissues. Thus, the homeostatic set point for basophils is influenced by the same cytokines and tissue signals that define type 2 inflammation.
Key Genes Involved in GO:1990960 basophil homeostasis
The following genes and proteins have documented roles in basophil biology, type 2 cytokine signaling or the inflammatory contexts in which basophil homeostasis is studied.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL3 | Cytokine that instructs basophil differentiation and survival | Cytokine instruction of basophil modulation |
| IL3RA | Receptor subunit for IL-3 signaling on basophils | Cytokine-dependent basophil survival |
| TSLP | Epithelial cytokine that instructs type 2 responses including basophil modulation | Barrier tissue type 2 inflammation |
| IL33 | Nuclear IL-1 family cytokine released as an alarmin acting on basophils and type 2 cells | Alarmin-driven basophil effector function |
| IL1RL1 | ST2 receptor for IL-33 on type 2 immune cells | IL-33 responsiveness in basophil biology |
| IL4 | Type 2 cytokine associated with basophil effector responses | Type 2 inflammation readouts |
| IL13 | Type 2 cytokine associated with basophil effector responses | Type 2 inflammation readouts |
| FCER1A | High-affinity IgE receptor alpha chain expressed on basophils | Basophil identification and activation |
| MS4A2 | IgE receptor beta chain involved in basophil activation | Basophil effector function |
| GATA2 | Transcription factor implicated in basophil and mast cell differentiation | Basophil differentiation studies |
| CEBPA | Transcription factor contributing to granulocyte differentiation programs | Basophil differentiation studies |
| STAT5 | Signaling mediator downstream of cytokine receptors in basophils | Cytokine instruction of basophils |
| STAT6 | Signaling mediator downstream of IL-4/IL-13 in type 2 cells | Type 2 cytokine signaling |
| IL2RA | Receptor subunit associated with cytokine signaling in immune cells | Cytokine-dependent immune cell homeostasis |
| IL7R | Receptor subunit associated with cytokine signaling in immune cells | Cytokine-dependent immune cell homeostasis |
| KIT | Receptor tyrosine kinase expressed on related granulocyte lineages | Lineage differentiation comparisons |
| CPA3 | Granule protease used as a basophil/mast cell marker | Basophil granule phenotyping |
| HDC | Histidine decarboxylase required for histamine synthesis in basophils | Basophil effector function |
How Is basophil homeostasis Regulated?
Basophil homeostasis is regulated primarily by cytokine instruction. Basophil modulation by cytokine instruction means that cytokines present in the microenvironment can change basophil differentiation, survival and effector state, thereby shifting the homeostatic set point. IL-3 and TSLP are prominent instructors of basophil responses, and their availability is influenced by barrier tissue signals. IL-33 is a nuclear cytokine of the IL-1 family that is released as an extracellular alarmin and acts on basophils and other type 2 immune cells, providing a tissue-derived regulatory input. In skin disorders, ILC2s and related type 2 circuits respond to such signals, indicating that basophil homeostasis is embedded in a broader regulatory network. During helminth infection, basophil effector function and homeostasis are actively modulated, showing that the regulatory system can be redeployed in response to infection. Together, these cytokine and tissue signals maintain a stable basophil pool under resting conditions while allowing rapid adjustment when needed.
basophil homeostasis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL33 | Type 2 inflammation in barrier tissues | Knockout and overexpression models in immune cells |
| IL1RL1 | IL-33 responsiveness in type 2 immunity | Point-mutation and knockout models |
| TSLP | Barrier tissue type 2 inflammation | Knockout and overexpression models |
| IL3 | Cytokine instruction of basophil modulation | Knockout and cytokine-reporter models |
| FCER1A | Basophil activation and effector function | Tagged knock-in and knockout models |
Atopic dermatitis and skin barrier dysfunction
Atopic dermatitis is a chronic inflammatory skin disease in which type 2 inflammation contributes to skin barrier dysfunction. Basophils are part of the type 2 immune landscape, and their homeostatic regulation influences the intensity of type 2 responses in skin. Because IL-33 is released as an alarmin in barrier tissues and acts on type 2 immune cells, dysregulated IL-33 signaling may perturb basophil homeostasis and amplify skin inflammation. ILC2s in skin disorders further highlight the type 2 network in which basophils operate. Studying GO:1990960 in the context of atopic dermatitis helps clarify how basophil numbers and function contribute to disease.
Chronic rhinosinusitis and nasal polyposis
Chronic rhinosinusitis with nasal polyposis is characterized by type 2 inflammation in the upper airway. Basophils and related type 2 cells contribute to the inflammatory milieu, and their homeostatic regulation affects the magnitude of the response. Cytokine instruction of basophils, including signals from the epithelial cytokine TSLP, links barrier tissue state to basophil modulation. IL-33 released as an alarmin can further shape type 2 responses in the airway. Thus, basophil homeostasis is relevant to understanding why some patients develop severe type 2 airway disease.
Helminth infection and immune defense
During helminth infection, basophil effector function and homeostasis are actively modulated as part of host defense. This context demonstrates that basophil homeostasis is not a fixed set point but a regulated process that can be adjusted in response to infection. Cytokine instruction provides the mechanistic basis for this flexibility, as cytokines can change basophil differentiation and survival. IL-33 released as an alarmin may also participate in the type 2 response to helminths. Studying GO:1990960 during helminth infection therefore provides insight into how the basophil pool is maintained and redeployed.
From basophil homeostasis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for basophil homeostasis? | CRISPR knockout in hematopoietic progenitor or basophil-like cell models |
| Does a specific point mutation alter basophil survival? | CRISPR point-mutation knock-in |
| Does a disease-associated variant change basophil numbers? | Knock-in of the variant with flow cytometry readout |
| Where is a basophil protein expressed and how does it traffic? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a cytokine or receptor expand basophils? | CRISPR overexpression models |
| Which genes regulate basophil differentiation at scale? | CRISPR library screening with cytokine and surface marker readouts |
How to Study the basophil homeostasis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Basophil frequency and surface phenotype | Quantifying homeostatic basophil numbers |
| Intracellular cytokine staining | IL-4 and IL-13 production in basophils | Assessing basophil effector state |
| Cytokine ELISA | Levels of IL-3, TSLP and IL-33 | Defining regulatory inputs |
| Single-cell RNA sequencing | Basophil heterogeneity and gene expression | Identifying homeostatic subpopulations |
| CRISPR knockout | Requirement of a gene for basophil homeostasis | Causal gene testing |
| CRISPR point mutation | Effect of a specific variant on basophil biology | Variant functional annotation |
| Tagged knock-in | Protein localization and expression | Tracking basophil proteins |
| Helminth infection model | Dynamic regulation of basophil homeostasis in vivo | Infection-driven basophil responses |
Flow cytometry for basophil identification and counting
Flow cytometry is the primary method for identifying and counting basophils, using surface markers such as FCER1A and MS4A2 and granule markers such as CPA3. Because basophils are rare, sensitive panels and adequate event numbers are required to detect changes in homeostatic set points. Flow cytometry can be combined with intracellular staining for cytokines such as IL-4 and IL-13 to assess effector state alongside number. This approach is central to testing whether a genetic perturbation alters basophil homeostasis.
Cytokine profiling and stimulation assays
Cytokine profiling measures the signals that instruct basophil differentiation and survival, including IL-3, TSLP and IL-33. Stimulation assays can test how basophils respond to these cytokines in vitro, providing functional readouts that complement enumeration. Because IL-33 is released as an alarmin, assays that detect extracellular IL-33 can link tissue signals to basophil responses. These methods help define the regulatory inputs that maintain basophil homeostasis.
Transcriptomics and single-cell analysis
Transcriptomic and single-cell approaches can resolve basophil heterogeneity and identify genes associated with homeostatic states. Recent reviews emphasize that basophil differentiation and heterogeneity have functional implications, making single-cell readouts valuable for defining subpopulations. These methods can also reveal how cytokine instruction reshapes basophil gene expression programs. When combined with genetic perturbation, transcriptomics can nominate candidate regulators of GO:1990960.
In vivo infection and inflammation models
In vivo models of helminth infection and allergic inflammation allow basophil homeostasis to be studied in a physiological context. Helminth infection is a classic setting in which basophil effector function and homeostasis are dynamically regulated. Atopic dermatitis and chronic rhinosinusitis models provide type 2 inflammatory contexts relevant to human disease. These models are essential for determining whether a gene identified in vitro truly affects basophil homeostasis in vivo.
How CRISPR Can Be Used to Study GO:1990960 basophil homeostasis
Knockout
CRISPR knockout is used to test whether a candidate gene is required for basophil homeostasis. By disrupting a gene in hematopoietic progenitors or basophil-like cell models, researchers can measure changes in basophil differentiation, survival and number. Knockout studies are particularly useful for genes identified by transcriptomic or single-cell screens as potential regulators of basophil heterogeneity. When combined with flow cytometry, knockout models provide direct causal evidence linking a gene to GO:1990960.
Point Mutation
CRISPR point mutation allows precise modeling of disease-associated or functional variants in genes related to basophil homeostasis. This approach is valuable when a candidate variant is suspected to alter cytokine signaling or survival pathways rather than simply abolish gene function. Point-mutation models can be paired with cytokine stimulation assays to determine whether the variant changes basophil responses to IL-3, TSLP or IL-33. Such experiments help translate genetic findings into mechanistic insight about basophil homeostasis.
Knock-in
CRISPR knock-in can be used to introduce reporters, tags or humanized sequences into genes relevant to basophil biology. Tagged knock-in models enable tracking of basophil proteins and can reveal where and when a protein is expressed during differentiation and homeostasis. Knock-in of disease-associated variants provides a controlled system to study their effects on basophil numbers and function. These models complement knockout approaches by preserving gene dosage and regulatory context.
Overexpression
CRISPR overexpression models test whether increasing the level of a cytokine, receptor or transcription factor expands or stabilizes the basophil pool. Overexpression is useful for genes such as IL3, TSLP or IL33, where excess signaling may shift the homeostatic set point. By combining overexpression with flow cytometry and cytokine profiling, researchers can determine whether a gene is sufficient to alter basophil homeostasis. These experiments complement loss-of-function studies to establish causality.
How EDITGENE Supports basophil homeostasis Research
Researchers studying basophil homeostasis-related genes often need to determine whether a candidate gene is causally involved in maintaining basophil numbers or function, rather than merely correlated with a disease state. This requires precise genetic models that can knock out, mutate, tag or overexpress the gene of interest in relevant immune cell contexts. EDITGENE provides CRISPR-based cell model services that support each of these experimental needs, from single-gene validation to library-scale screening, with bioinformatics support for interpreting the resulting data.
Contact EDITGENE today to design your custom CRISPR model for basophil homeostasis research.
Frequently Asked Questions About basophil homeostasis
What is GO:1990960 basophil homeostasis?
GO:1990960 basophil homeostasis is the biological process that regulates the proliferation and elimination of basophils so that the total number of basophils remains stable over time in the absence of an outside stimulus.
What is the definition of basophil homeostasis?
The QuickGO definition states that it is the process of regulating the proliferation and elimination of basophils such that the total number of basophils within a whole or part of an organism is stable over time in the absence of an outside stimulus.
What genes are involved in basophil homeostasis?
Genes involved in basophil biology include IL3, IL3RA, TSLP, IL33, IL1RL1, IL4, IL13, FCER1A, MS4A2, GATA2, CEBPA, STAT5, STAT6, CPA3 and HDC, based on their roles in basophil differentiation, cytokine signaling and effector function.
How are basophils regulated by cytokines?
Basophils are modulated by cytokine instruction, meaning cytokines such as IL-3 and TSLP can change their differentiation, survival and effector state, thereby shifting the homeostatic set point.
What is the role of IL-33 in basophil biology?
IL-33 is a nuclear cytokine of the IL-1 family that is released as an extracellular alarmin and acts on basophils and other type 2 immune cells, influencing their effector function and tissue environment.
How is basophil homeostasis studied experimentally?
It is studied using flow cytometry to count basophils, cytokine profiling to measure regulatory inputs, transcriptomics to resolve heterogeneity, and in vivo infection or inflammation models to test physiological relevance.
What diseases are linked to basophil homeostasis?
Dysregulated basophil homeostasis is linked to type 2 inflammatory diseases such as atopic dermatitis, chronic rhinosinusitis and nasal polyposis, and to helminth infection responses.
Can CRISPR be used to study basophil homeostasis?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models can test whether a candidate gene causally alters basophil numbers or function.
What is the synonym for GO:1990960?
The synonym is basophilic leucocyte homeostasis.
Why is basophil homeostasis important for drug discovery?
Because basophils contribute to type 2 inflammation in barrier tissues, understanding their homeostatic regulation may inform therapeutic strategies for atopic dermatitis and chronic rhinosinusitis.
Conclusion
GO:1990960 basophil homeostasis defines the regulatory process that keeps basophil numbers stable over time in the absence of an outside stimulus. It is driven by cytokine instruction, tissue-derived alarmins such as IL-33, and the balance between basophil production and elimination. Because basophils are rare but potent contributors to type 2 inflammation, their homeostatic regulation is relevant to atopic dermatitis, chronic rhinosinusitis and helminth infection. CRISPR-based models provide a direct way to test candidate genes for causal roles in this process, and continued work in this area will clarify how the basophil pool is maintained and redeployed in health and disease.
References
- 1. Beck LA et al.. 2022. Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.. JID Innov 2(5):100131 PMID: 36059592
- 2. Schleimer RP. 2017. Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis.. Annu Rev Pathol 12:331-357 PMID: 27959637
- 3. Cayrol C et al.. 2022. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.. Cytokine 156:155891 PMID: 35640416
- 4. Cayrol C et al.. 2018. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.. Immunol Rev 281(1):154-168 PMID: 29247993
- 5. Chen Y et al.. 2024. Basophil differentiation, heterogeneity, and functional implications.. Trends Immunol 45(7):523-534 PMID: 38944621
- 6. Voehringer D. 2012. Basophil modulation by cytokine instruction.. Eur J Immunol 42(10):2544-50 PMID: 23042651
- 7. Imai Y. 2023. ILC2s in skin disorders.. Allergol Int 72(2):201-206 PMID: 36842916
- 8. Ohnmacht C et al.. 2009. Basophil effector function and homeostasis during helminth infection.. Blood 113(12):2816-25 PMID: 18941115
